A late-July U.S.-EU trade deal capped most EU imports, including pharmaceuticals, at 15%, easing fears of triple-digit levies and supporting a rebound in life-sciences tools shares. On July 23, Thermo Fisher raised the lower end of guidance and said the tariff situation was improving, reinforcing the risk-relief trade. Danaher and Agilent also have reported their… The post As tariff relief lifts sector, Thermo Fisher pulls ahead while Waters continues to navigate $17.5B deal appeared first ...| Research & Development World
AI isn’t some shiny new kid on the drug discovery block. In one way or another, it’s been lurking in labs for decades under aliases like computational chemistry and cheminformatics. The term ‘artificial intelligence’ itself dates back to the 1950s. Alister Campbell, vice president and global head of science and technology at Dotmatics, chuckles at… The post How AI Is upgrading the drug hunter while driving leaner, meaner teams appeared first on Research & Development World.| Research & Development World
The official 2025 R&D 100 Awards have been announced by R&D World. This worldwide science and innovation competition, now in its 63rd year, received entries from organizations around the world. This year’s judging panel included industry professionals from across the globe who evaluated breakthrough innovations in technology and science. The Winners are listed below by… The post Revealing the 2025 R&D 100 Awards Winners appeared first on Research & Development World.| Research & Development World
Meissner has launched its RMS (Rotary Impeller Mixing Solutions) portfolio, a line of biocontainer mixing assemblies designed for drop-in compatibility with existing bioprocessing equipment. The product line is designed to provide mixing assemblies compatible with industry-standard tanks and existing drive units, without requiring additional hardware or modifications. RMS assemblies use Meissner’s TepoFlex® polyethylene (PE) multi-layer… The post Meissner launches rotary impeller mixing ...| Research & Development World
R&D World has announced the winners of the 2025 R&D 100 Professional Awards. The honorees were selected by a panel of 54 prestigious industry experts from around the globe. The list of 2025 winners follows, along with highlights from their nomination letters. These winners will be formally awarded at the R&D 100 Awards Banquet at… The post R&D World announces 2025 R&D 100 Professional Award Winners appeared first on Research & Development World.| Research & Development World
Obesity changes gut microbiota, causing immune cells to age prematurely and secrete a protein which weakens bones The post Bone loss in obesity traced to gut microbiota appeared first on Advanced Science News.| Advanced Science News
KNOXVILLE, Tenn. – The Spark Innovation Center at the University of Tennessee Research Park is proud to announce the addition of Tim Rinks as its newest Life Science Expert-in-Residence (EIR). With decades of leadership in pharmaceuticals, medical devices, and healthcare innovation, Rinks brings a wealth of experience from Fortune 500 companies and high-growth startups to Spark’s entrepreneurial ecosystem.| The University of Tennessee Research Park at Cherokee Farm
Trump's energy bill threatens green power, Tesla stock tumbles — again, AI models achieve 30% better results through collaboration, Moderna's mRNA flu vaccine shows 26.6% superiority.| Research & Development World
Infected fruit flies use behavioral fever against deadly parasitoid wasps. The post Behavioral Fever Helps Fight Parasitic Infections appeared first on Advanced Science News.| Advanced Science News
Why does Roche’s oncology blockbuster Herceptin (trastuzumab) have 1,536 patents in a comprehensive search of international patents but only 393 when searching for patent titles? This four-fold difference is a window into pharmaceutical strategy.| Research & Development World
Neovate will invest in start-up MedTech and BioPharma companies in the Pittsburgh area. Governor Josh Shapiro’s 2025-26 budget proposal includes a new $50 million investment to create the PA Innovation […]| PA Department of Community & Economic Development
Cats Don’t Talk We humans have perhaps 100 billion neurons in our brains. But what if we had many more? Or what if the AIs we built effectively had many more? What kinds of things might then become possible? At 100 billion neurons, we know, for example, that compositional language of the kind we humans […]| Stephen Wolfram Writings
By furthering our investment in women’s cancer datasets, COTA is eager to collaborate with industry partners on accelerating research into these conditions with the goal of improving experiences and outcomes for the hundreds of thousands of women affected by cancer every year.| COTA Healthcare
We’re setting our sights on solid tumors to bring even more clarity and understanding to the cancer community. Our datasets now include longitudinal treatment and outcomes data for a broad array of solid tumors.| COTA Healthcare
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]| COTA Healthcare
CAILIN addresses these questions through training on COTA's proprietary datasets while guided by in-house oncology expertise. CAILIN expedites access to data and oncology-specific insights across the pharmaceutical R&D life cycle and, in the near future, will provide additional ways to develop hypotheses and generate evidence.| COTA Healthcare
Coming up with the most effective and suitable life sciences marketing strategies is no rocket science, but it is also no child’s play either. Some of the crucial aspects worth noting in this case is the fact that marketing in this domain is mostly in the B2B (business-to-business) segment and also that it should be … Continue reading Effective Performing Marketing Strategies In Life Sciences Industry The post Effective Performing Marketing Strategies In Life Sciences Industry appeared fi...|
Stephen Wolfram takes the first steps in developing a medical metamodel framework for studying and formalizing the abstract foundations of medicine.| writings.stephenwolfram.com
Additional implications for the foundations of biological evolution found in the adaptive cellular automaton model that Stephen Wolfram introduced in an earlier post.| writings.stephenwolfram.com
In the realm of life sciences research and development (R&D), generative AI holds transformative potential, accelerating advancements in drug discovery and optimising clinical trials. Yet, data privacy and regulatory compliance present significant barriers to its widespread adoption. Navigating these complexities is crucial for life sciences organisations to harness AI’s power while safeguarding sensitive data and … Continue reading Overcoming Barriers to Generative AI in Life Sciences R&...|
CRAMS or Contract Research and Manufacturing Services can be a game-changer for the life sciences industry. In fact, if you’re in this sector, then opting for suitable contract research outfits will help you enhance your game to a new level altogether. So what does this market cover? This essentially involves outsourcing multiple R&D (research and development) … Continue reading Level Up Your Research: How CRAMS Can Boost Your Life Sciences Game| www.indusnet.co.in
Stephen Wolfram explores simple models of biological organisms as computational systems. A study of progressive development, multiway graphs of all possible paths and the need for narrowing the framework space.| writings.stephenwolfram.com
